Rigel Pharmaceuticals, Inc. (RIGL) Social Stream
RIGEL PHARMACEUTICALS INC (RIGL) Price Targets From Analysts
Use the tables below to see what analysts covering RIGEL PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 4 | $11 | $7 | $8.5 | $1.34 | 534.33% |
| 2022-03-02 | 4 | $11 | $7 | $8.25 | $1.34 | 515.67% |
| 2022-05-03 | 5 | $11 | $4 | $7.4 | $1.34 | 452.24% |
| 2022-05-05 | 5 | $11 | $4 | $7.2 | $1.34 | 437.31% |
| 2022-06-09 | 7 | $7 | $0.8 | $2.008 | $1.34 | 49.85% |
| 2022-07-25 | 7 | $7 | $0.8 | $2.15 | $1.34 | 60.45% |
| 2022-08-03 | 7 | $7 | $0.8 | $2.392 | $1.34 | 78.51% |
| 2022-10-11 | 7 | $15 | $0.8 | $3.678 | $1.34 | 174.48% |
| 2022-11-06 | 7 | $15 | $0.8 | $3.535 | $1.34 | 163.81% |
| 2022-12-02 | 7 | $15 | $0.8 | $3.478 | $1.34 | 159.55% |
| 2023-03-08 | 7 | $15 | $0.8 | $3.492 | $1.34 | 160.6% |
| 2023-03-09 | 7 | $15 | $1.2 | $4.325 | $1.34 | 222.76% |
| 2023-05-03 | 7 | $15 | $1.2 | $3.993 | $1.34 | 197.99% |
| 2023-08-02 | 6 | $15 | $1.2 | $4.158 | $1.34 | 210.3% |
| 2023-11-08 | 6 | $15 | $1.3 | $4.175 | $1.34 | 211.57% |
| 2023-11-09 | 6 | $15 | $1 | $4.041 | $1.34 | 201.57% |
The Trend in the Analyst Price Target
RIGL's average price target has moved down $4.46 over the prior 30 months.
Over the past 35 weeks, RIGL's average upside potential has been 236.42%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 7 | 15 | 1.2 | 3.992 | 1.68 | 137.62% |
| 2023-05-03 | 6 | 15 | 1.2 | 3.993 | 1.15 | 247.22% |
| 2023-08-02 | 6 | 15 | 1.2 | 4.158 | 1.29 | 222.33% |
| 2023-08-02 | 6 | 15 | 1.3 | 4.175 | 1.29 | 223.64% |
| 2023-10-11 | 6 | 15 | 1.3 | 4.175 | 1.00 | 317.5% |
RIGL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 4 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 26 weeks, RIGL's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, RIGEL PHARMACEUTICALS INC's average analyst price target is greater than 81.97% of them.
- To contextualize these metrics, consider that out of all US stocks, RIGEL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1800.69% of them.
- RIGL has a higher number of analysts covering the stock than 1459.22% of stocks in the small market cap category.
- RIGL has a higher upside potential (average analyst target price relative to current price) than 1423.27% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ANIP, SEEL, and SIGA are the three stocks most similar to RIGEL PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RIGL a Buy, Hold or Sell? See the POWR Ratings now!